Advait Gupta

5682 POSTS
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Exclusive articles:

When Artificial Intelligence Bots Impersonate Humans

Stay up-to-date on the latest tech news from artificial intelligence to fintech and cybersecurity. Attend TechCrunch Disrupt 2023 in San Francisco and save up to $600 with promo code STARTUPS.

Reddit Must Still Face Simmering Rage from Users Returning to the Platform

Despite recent protests over Reddit's API pricing policy, the platform has returned to normal. However, the simmering rage still persists. Can Reddit's changes help them become a self-sustaining business?

AI and the Future of Travel, Survey Reveals Investor Interest in Fusion Energy, Reasons Why Your Startup May Never Get Funded: TechCrunch+ Roundup

Stay on top of the latest in tech and business with TechCrunch's latest roundup. From AI integration to Black founders' venture capital challenges, learn how to pivot to success.

HRtech Startups Quietly Build Toward $24B Market Amid AI Buzz

Discover the under-the-radar potential of HRtech startups. Despite lacking buzz, it's a fast-growing $24B industry expected to produce the next tech giants. Keep an eye out for investment opportunities.

Powerful PDF Tools Now Available in Google Chrome Browser with a Limitation

Google announces new PDF editor capability for Chrome browser with Optical Character Recognition (OCR) technology to improve web accessibility for users with sight and reading difficulties.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img